Meta’s Threads micro-blogging app now has 275 million monthly users, Zuckerberg says

Meta’s Threads micro-blogging app now has 275 million monthly users, Zuckerberg says


Meta CEO Mark Zuckerberg holds a smartphone, as he makes a keynote speech at the Meta Connect annual event, at the company’s headquarters in Menlo Park, California, U.S. September 25, 2024. 

Manuel Orbegozo | Reuters

Threads, Meta‘s rival to Elon Musk’s X app, now has nearly 275 million monthly users, CEO Mark Zuckerberg said Wednesday.

“We continue to be on track towards this becoming our next major social app,” Zuckerberg said on a call with analysts, adding that he was “quite pleased” with the trajectory of the app.

The latest numbers indicate Threads is up 175% from a year ago when it reached 100 million users. The app is also up from 200 million monthly actives since Meta’s second-quarter report in July. The app is now signing up more than 1 million users per day, Zuckerberg also said on Wednesday.

Threads launched in July 2023 as a rival to Musk-owned X, who closed a deal to purchase the social app formerly known as Twitter in October 2022 for $44 billion.

X remains ahead of Threads in terms of users, with a market intelligence firm estimating that X has roughly 318 million monthly users in October 2024. That’s down 24% since Musk completed his acquisition of the company in October 2022, according to Sensor Tower.

Threads could provide Meta more places to deliver ads to users. Ads accounted for 98.3% of Meta’s total revenue in the third quarter.

“Specifically, as it pertains to monetization, we don’t expect Threads to be a meaningful driver of 2025 revenue at this time,” said CFO Susan Li on the earnings call. “We’ve been just pleased with the growth trajectory and again, are really focused on introducing features that the community finds valuable.”

Analysts at Bernstein wrote on Wednesday that Threads’ growth provides a lot to get excited about.

“Even though Meta does not expect Threads to be a meaningful driver of 2025 revenue, we expect ads to show up and scale on Threads next year,” the Bernstein analysts wrote.

Across Meta’s family of apps, which includes Facebook, Instagram and its other consumer-facing platforms, the company said its daily active people grew 5% year-over-year to reach 3.29 billion. That figure came in below analysts’ expectations of 3.31 billion.

Meta shares were down roughly 4% on Thursday.

“We’re very focused on continuing to build out the sort of functionality of Threads over time and being responsive to what users tell us that they’re interested in,” Li said.

WATCH: Meta already benefitting from AI but Microsoft still ‘needs to find gold,’ says DA Davidson’s Luria

Meta already benefitting from AI but Microsoft still 'needs to find gold,' says DA Davidson's Luria



Source

JPMorgan CEO Jamie Dimon says the bank will let clients buy bitcoin
Technology

JPMorgan CEO Jamie Dimon says the bank will let clients buy bitcoin

JPMorgan Chase CEO Jamie Dimon delivers a speech during the Global Markets Conference, ahead of the Choose France summit, in Paris, on May 15, 2025. Michel Euler | Afp | Getty Images JPMorgan Chase is finally allowing clients to buy bitcoin. But CEO Jamie Dimon is still a skeptic. “We are going to allow you […]

Read More
Microsoft introduces GitHub AI agent that can code for you
Technology

Microsoft introduces GitHub AI agent that can code for you

Microsoft CEO Satya Nadella speaks at an event commemorating the 50th anniversary of the company at Microsoft headquarters in Redmond, Washington, on , April 4, 2025. David Ryder | Bloomberg | Getty Images Microsoft’s GitHub unit on Monday introduced a Copilot artificial intelligence agent that can take on specific programming work and inform people once […]

Read More
Regeneron Pharmaceuticals to buy 23andMe and its data for 6 million
Technology

Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

A view of the 23andMe headquarters in Sunnyvale, California, on March 25, 2025. Tayfun Coskun | Anadolu | Getty Images Regeneron Pharmaceuticals on Monday announced it will acquire “substantially all” of 23andMe’s assets for $256 million. The drugmaker participated in a bankruptcy auction for 23andMe, a once high-flying genetic testing company that filed for for […]

Read More